HOXA9 and head and neck squamous cell carcinoma: HOXA9 acted as a cancer promoter in head and neck squamous cell carcinoma (HNSCC) and laryngeal squamous cell carcinoma to promote the proliferation and migration of cancer cells [48, 49].